LONG WuxiBiologicsWuXi Biologics outstanding CRDMO in biotech sector is preparing for a bullrun. Beside the Biosecure Act of US. The stock looks attractive.
Prepare for corrective move to the upside.
A2PQ3Q trade ideas
Wuxi Biologics (2269): Incredible long-term opportunity! Wuxi Biologics (2269): HKEX:2269
Wuxi Biologics, a Chinese biotech research company listed on the Hong Kong Stock Exchange, presents a complex investment scenario. It's crucial to note we're dealing with the Hong Kong Dollar, not the US dollar. The comprehensive analysis on the weekly chart suggests that since June 2021, the company has been undergoing a correction defense scenario. This downturn has been so pronounced that the stock might need to reach its origin point at 8.56 HKD to complete the correction cycle of Wave 2 through Wave (Y) in blue. This process is expected to involve an initial surge followed by a downturn.
While there's potential for early position building, the decision to do so carries its uncertainties, given regulatory concerns and the stock's unpredictable future. Our strategy is to remain patient, observing how events unfold. Even with a 30% stop-loss threshold, which practically doesn't apply given the upside, we anticipate a minimum 2600% movement for Wave III in red, with the potential to reach an extraordinary 6000% at maximum. Such figures outline the vast upward trajectory expected, not just through Wave 3 but also with an ensuing Wave V.
Therefore, we are comfortable waiting and watching for the right entry point. Even if we decide to enter the market at a later stage, we expect that Wuxi Biologics will still offer significant opportunities.
2269.HK is going to fly ~ (1st target: 77.8, 2nd target: 90.05)2269.HK has experienced a long decline for more than 1 year due to local and oversea government policies, although its P&L has growth a lot. 2269.HK is going to complete a head and shoulder pattern within the last 70 days, and highly likely to fly in the near term. The first target will be 77.8 and second target will be 90.05.
On the other hand, China government is likely to support health and medical industry just to ensure the GDP growth can be met ( 5-6% target this year).
WUXI Biologics dropped by 5%, good time to add! WUXI Biologics dropped by 5%, forming a bullish M pattern! Good time to add since nothing changed in fundamentals and this is a selloff by the Capital Group probably due to profit taking.
Price broke below the trendline, could be a fakeout! Price broke below the trendline, could be a fakeout! Fundamentals are still strong for equity market, not worrying about crash, but think it could be a good pullback to add some positions here !
2269HKEX:2269
Fast Turtle Buy
FiFT +VE Recharge
MCDX+ Spike Up +ve
Banker 90%
Atom is on highway
Resistance turn support
SL Below 105
Want subscribe Turtle Trading System pls PM ME
WUXI BIOLOGICS - Chinese Drug Developer - Nice PullbackWUXI traded on the Hong Kong Exchange as 2269 has had a great run over the last 12 months, up some 210% post March 2020.
Nice big pullback to a value / support area. Could be worth a look if it heads back up.
One Year View
Wuxi Biologics Cayman Inc (2269 - HK) - 5th wave upWuxi Biologics Cayman Inc (2269 - HK) is in 5th wave up of major 5th wave of C wave up in daily time frame. It is now in 5th wave up after sharp 4th wave ended just above wave 1 territory. It also be possible that extension is on the way. But conservatively it is now in 5th wave progress with small invalidation level between. It is also in strong uptrend and out-performing HSI.
HKEX:2269 Short term 20 days. Potential profit 9.58%HKEX:2269
Buy in at 118
Cut loss at 112.4
Target at 129.3
